Does the media favor FENC or ANIP?

In the previous week, ANI Pharmaceuticals had 7 more articles in the media than Adherex Technologies. MarketBeat recorded 10 mentions for ANI Pharmaceuticals and 3 mentions for Adherex Technologies. ANI Pharmaceuticals' average media sentiment score of 0.77 beat Adherex Technologies' score of 0.45 indicating that ANI Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adherex Technologies 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ANI Pharmaceuticals 4 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer FENC or AVLN?

In the previous week, Avalyn Pharma had 8 more articles in the media than Adherex Technologies. MarketBeat recorded 11 mentions for Avalyn Pharma and 3 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 0.45 beat Avalyn Pharma's score of 0.39 indicating that Adherex Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adherex Technologies 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avalyn Pharma 2 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer LBRX or FENC?

In the previous week, Adherex Technologies had 2 more articles in the media than LB Pharmaceuticals. MarketBeat recorded 3 mentions for Adherex Technologies and 1 mentions for LB Pharmaceuticals. LB Pharmaceuticals' average media sentiment score of 1.67 beat Adherex Technologies' score of 0.45 indicating that LB Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LB Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Adherex Technologies 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer INVA or FENC?

In the previous week, Innoviva had 3 more articles in the media than Adherex Technologies. MarketBeat recorded 6 mentions for Innoviva and 3 mentions for Adherex Technologies. Innoviva's average media sentiment score of 0.93 beat Adherex Technologies' score of 0.45 indicating that Innoviva is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Innoviva 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Adherex Technologies 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor FENC or PAHC?

In the previous week, Phibro Animal Health had 12 more articles in the media than Adherex Technologies. MarketBeat recorded 15 mentions for Phibro Animal Health and 3 mentions for Adherex Technologies. Phibro Animal Health's average media sentiment score of 0.88 beat Adherex Technologies' score of 0.45 indicating that Phibro Animal Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adherex Technologies 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Phibro Animal Health 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Adherex Technologies (FENC) Competitors

$10.51 -0.50 (-4.54%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$10.51 0.00 (0.00%)

As of 09/23/2026 07:30 PM Eastern

Compare

FENC vs. ANIP, AVLN, LBRX, INVA, and PAHC

Should you buy Adherex Technologies stock or one of its competitors? Adherex Technologies's main competitors and comparable companies include ANI Pharmaceuticals (ANIP), Avalyn Pharma (AVLN), LB Pharmaceuticals (LBRX), Innoviva (INVA), and Phibro Animal Health (PAHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Adherex Technologies compare to ANI Pharmaceuticals?

Adherex Technologies (NASDAQ:FENC) and ANI Pharmaceuticals (NASDAQ:ANIP) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, media sentiment, dividends and valuation.

55.5% of Adherex Technologies shares are owned by institutional investors. Comparatively, 76.1% of ANI Pharmaceuticals shares are owned by institutional investors. 10.7% of Adherex Technologies shares are owned by insiders. Comparatively, 8.1% of ANI Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

ANI Pharmaceuticals has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than ANI Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adherex Technologies	$44.64M	8.25	-$9.74M	-$0.13	N/A
ANI Pharmaceuticals	$883.37M	1.94	$78.34M	$4.64	16.04

Adherex Technologies presently has a consensus target price of $17.00, suggesting a potential upside of 61.75%. ANI Pharmaceuticals has a consensus target price of $98.00, suggesting a potential upside of 31.67%. Given Adherex Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe Adherex Technologies is more favorable than ANI Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
ANI Pharmaceuticals	0 Sell rating(s)	5 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.38

Adherex Technologies has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, ANI Pharmaceuticals has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market.

In the previous week, ANI Pharmaceuticals had 7 more articles in the media than Adherex Technologies. MarketBeat recorded 10 mentions for ANI Pharmaceuticals and 3 mentions for Adherex Technologies. ANI Pharmaceuticals' average media sentiment score of 0.77 beat Adherex Technologies' score of 0.45 indicating that ANI Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adherex Technologies	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ANI Pharmaceuticals	4 Very Positive mention(s)	3 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ANI Pharmaceuticals has a net margin of 11.07% compared to Adherex Technologies' net margin of -6.09%. ANI Pharmaceuticals' return on equity of 27.37% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adherex Technologies	-6.09%	-5.71%	-2.37%
ANI Pharmaceuticals	11.07%	27.37%	10.47%

Summary

ANI Pharmaceuticals beats Adherex Technologies on 10 of the 16 factors compared between the two stocks.

How does Adherex Technologies compare to Avalyn Pharma?

Adherex Technologies (NASDAQ:FENC) and Avalyn Pharma (NASDAQ:AVLN) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, risk, analyst recommendations, valuation, institutional ownership, profitability, media sentiment and earnings.

In the previous week, Avalyn Pharma had 8 more articles in the media than Adherex Technologies. MarketBeat recorded 11 mentions for Avalyn Pharma and 3 mentions for Adherex Technologies. Adherex Technologies' average media sentiment score of 0.45 beat Avalyn Pharma's score of 0.39 indicating that Adherex Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adherex Technologies	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avalyn Pharma	2 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Adherex Technologies currently has a consensus target price of $17.00, suggesting a potential upside of 61.75%. Avalyn Pharma has a consensus target price of $60.00, suggesting a potential upside of 102.22%. Given Avalyn Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Avalyn Pharma is more favorable than Adherex Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Avalyn Pharma	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	2.83

Avalyn Pharma has lower revenue, but higher earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Avalyn Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adherex Technologies	$44.64M	8.25	-$9.74M	-$0.13	N/A
Avalyn Pharma	N/A	N/A	N/A	-$22.81	N/A

Avalyn Pharma has a net margin of 0.00% compared to Adherex Technologies' net margin of -6.09%. Avalyn Pharma's return on equity of 0.00% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adherex Technologies	-6.09%	-5.71%	-2.37%
Avalyn Pharma	N/A	N/A	N/A

55.5% of Adherex Technologies shares are owned by institutional investors. 10.7% of Adherex Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Avalyn Pharma beats Adherex Technologies on 8 of the 14 factors compared between the two stocks.

How does Adherex Technologies compare to LB Pharmaceuticals?

LB Pharmaceuticals (NASDAQ:LBRX) and Adherex Technologies (NASDAQ:FENC) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, profitability, dividends, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Adherex Technologies had 2 more articles in the media than LB Pharmaceuticals. MarketBeat recorded 3 mentions for Adherex Technologies and 1 mentions for LB Pharmaceuticals. LB Pharmaceuticals' average media sentiment score of 1.67 beat Adherex Technologies' score of 0.45 indicating that LB Pharmaceuticals is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LB Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Adherex Technologies	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

55.5% of Adherex Technologies shares are owned by institutional investors. 5.8% of LB Pharmaceuticals shares are owned by insiders. Comparatively, 10.7% of Adherex Technologies shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

LB Pharmaceuticals has a net margin of 0.00% compared to Adherex Technologies' net margin of -6.09%. Adherex Technologies' return on equity of -5.71% beat LB Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LB Pharmaceuticals	N/A	-25.92%	-24.68%
Adherex Technologies	-6.09%	-5.71%	-2.37%

LB Pharmaceuticals currently has a consensus price target of $49.63, indicating a potential upside of 26.63%. Adherex Technologies has a consensus price target of $17.00, indicating a potential upside of 61.75%. Given Adherex Technologies' higher probable upside, analysts clearly believe Adherex Technologies is more favorable than LB Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LB Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Adherex Technologies has higher revenue and earnings than LB Pharmaceuticals. Adherex Technologies is trading at a lower price-to-earnings ratio than LB Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LB Pharmaceuticals	N/A	N/A	-$25.20M	-$3.44	N/A
Adherex Technologies	$44.64M	8.25	-$9.74M	-$0.13	N/A

Summary

Adherex Technologies beats LB Pharmaceuticals on 9 of the 15 factors compared between the two stocks.

How does Adherex Technologies compare to Innoviva?

Innoviva (NASDAQ:INVA) and Adherex Technologies (NASDAQ:FENC) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

Innoviva has a beta of 0.33, suggesting that its stock price is 67% less volatile than the broader market. Comparatively, Adherex Technologies has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market.

Innoviva has a net margin of 81.19% compared to Adherex Technologies' net margin of -6.09%. Innoviva's return on equity of 28.03% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Innoviva	81.19%	28.03%	20.19%
Adherex Technologies	-6.09%	-5.71%	-2.37%

99.1% of Innoviva shares are owned by institutional investors. Comparatively, 55.5% of Adherex Technologies shares are owned by institutional investors. 2.0% of Innoviva shares are owned by company insiders. Comparatively, 10.7% of Adherex Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Innoviva has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Innoviva, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Innoviva	$411.33M	3.56	$271.17M	$4.10	4.94
Adherex Technologies	$44.64M	8.25	-$9.74M	-$0.13	N/A

Innoviva presently has a consensus target price of $34.80, indicating a potential upside of 71.94%. Adherex Technologies has a consensus target price of $17.00, indicating a potential upside of 61.75%. Given Innoviva's stronger consensus rating and higher probable upside, analysts plainly believe Innoviva is more favorable than Adherex Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Innoviva	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, Innoviva had 3 more articles in the media than Adherex Technologies. MarketBeat recorded 6 mentions for Innoviva and 3 mentions for Adherex Technologies. Innoviva's average media sentiment score of 0.93 beat Adherex Technologies' score of 0.45 indicating that Innoviva is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Innoviva	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Adherex Technologies	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Innoviva beats Adherex Technologies on 13 of the 16 factors compared between the two stocks.

How does Adherex Technologies compare to Phibro Animal Health?

Adherex Technologies (NASDAQ:FENC) and Phibro Animal Health (NASDAQ:PAHC) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability, earnings and media sentiment.

Phibro Animal Health has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adherex Technologies	$44.64M	8.25	-$9.74M	-$0.13	N/A
Phibro Animal Health	$1.52B	0.91	$99.72M	$2.44	13.98

Phibro Animal Health has a net margin of 6.57% compared to Adherex Technologies' net margin of -6.09%. Phibro Animal Health's return on equity of 37.86% beat Adherex Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Adherex Technologies	-6.09%	-5.71%	-2.37%
Phibro Animal Health	6.57%	37.86%	9.18%

Adherex Technologies currently has a consensus target price of $17.00, suggesting a potential upside of 61.75%. Phibro Animal Health has a consensus target price of $47.67, suggesting a potential upside of 39.78%. Given Adherex Technologies' higher probable upside, equities research analysts clearly believe Adherex Technologies is more favorable than Phibro Animal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adherex Technologies	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
Phibro Animal Health	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.75

55.5% of Adherex Technologies shares are owned by institutional investors. Comparatively, 99.3% of Phibro Animal Health shares are owned by institutional investors. 10.7% of Adherex Technologies shares are owned by company insiders. Comparatively, 50.1% of Phibro Animal Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Adherex Technologies has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market. Comparatively, Phibro Animal Health has a beta of 0.46, indicating that its stock price is 54% less volatile than the broader market.

In the previous week, Phibro Animal Health had 12 more articles in the media than Adherex Technologies. MarketBeat recorded 15 mentions for Phibro Animal Health and 3 mentions for Adherex Technologies. Phibro Animal Health's average media sentiment score of 0.88 beat Adherex Technologies' score of 0.45 indicating that Phibro Animal Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Adherex Technologies	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Phibro Animal Health	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Phibro Animal Health beats Adherex Technologies on 13 of the 17 factors compared between the two stocks.

Get Adherex Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

FENC vs. The Competition

Export

Metric	Adherex Technologies	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$385.99M	$12.60B	$7.31B	$13.29B
Dividend Yield	N/A	2.63%	2.52%	12.57%
P/E Ratio	-80.85	792.28	274.02	25.69
Price / Sales	8.25	860.20	633.28	76.04
Price / Cash	N/A	88.64	77.80	52.76
Price / Book	10.11	10.62	10.44	6.32
Net Income	-$9.74M	$2.81B	$3.49B	$359.73M
7 Day Performance	-2.50%	-0.08%	-0.66%	0.17%
1 Month Performance	-7.81%	-1.31%	-3.16%	-3.27%
1 Year Performance	25.12%	2.91%	15.15%	5.58%

Adherex Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
FENC Adherex Technologies	4.1718 of 5 stars	$10.51 -4.5%	$17.00 +61.8%	+23.8%	$385.99M	$44.64M	N/A	35	News Coverage
ANIP ANI Pharmaceuticals	4.4264 of 5 stars	$71.46 +1.1%	$105.57 +47.7%	-21.9%	$1.62B	$883.37M	15.40	600	News Coverage Analyst Forecast
AVLN Avalyn Pharma	3.5089 of 5 stars	$34.67 -3.4%	$60.00 +73.1%	N/A	$1.59B	N/A	N/A	51	Positive News
LBRX LB Pharmaceuticals	2.6511 of 5 stars	$46.25 -3.0%	$49.63 +7.3%	+163.0%	$1.54B	N/A	N/A	16
INVA Innoviva	2.7872 of 5 stars	$20.62 -2.4%	$34.75 +68.5%	+6.0%	$1.53B	$411.33M	5.03	100	News Coverage Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:FENC) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adherex Technologies (FENC) Competitors

FENC vs. ANIP, AVLN, LBRX, INVA, and PAHC

How does Adherex Technologies compare to ANI Pharmaceuticals?

Summary

How does Adherex Technologies compare to Avalyn Pharma?

Summary

How does Adherex Technologies compare to LB Pharmaceuticals?

Summary

How does Adherex Technologies compare to Innoviva?

Summary

How does Adherex Technologies compare to Phibro Animal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC vs. The Competition

Adherex Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adherex Technologies (FENC) Competitors

FENC vs. ANIP, AVLN, LBRX, INVA, and PAHC

How does Adherex Technologies compare to ANI Pharmaceuticals?

Do institutionals and insiders have more ownership in FENC or ANIP?

Which has higher valuation & earnings, FENC or ANIP?

Do analysts prefer FENC or ANIP?

Which has more risk & volatility, FENC or ANIP?

Does the media favor FENC or ANIP?

Is FENC or ANIP more profitable?

Summary

How does Adherex Technologies compare to Avalyn Pharma?

Does the media prefer FENC or AVLN?

Do analysts prefer FENC or AVLN?

Which has stronger valuation and earnings, FENC or AVLN?

Is FENC or AVLN more profitable?

Do insiders & institutionals have more ownership in FENC or AVLN?

Summary

How does Adherex Technologies compare to LB Pharmaceuticals?

Does the media prefer LBRX or FENC?

Do institutionals & insiders believe in LBRX or FENC?

Is LBRX or FENC more profitable?

Do analysts recommend LBRX or FENC?

Which has stronger earnings and valuation, LBRX or FENC?

Summary

How does Adherex Technologies compare to Innoviva?

Which has more volatility & risk, INVA or FENC?

Is INVA or FENC more profitable?

Do institutionals and insiders believe in INVA or FENC?

Which has better valuation and earnings, INVA or FENC?

Do analysts recommend INVA or FENC?

Does the media prefer INVA or FENC?

Summary

How does Adherex Technologies compare to Phibro Animal Health?

Which has preferable valuation & earnings, FENC or PAHC?

Is FENC or PAHC more profitable?

Do analysts rate FENC or PAHC?

Do institutionals & insiders hold more shares of FENC or PAHC?

Which has more volatility & risk, FENC or PAHC?

Does the media favor FENC or PAHC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC vs. The Competition

Adherex Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools